Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
All HH‑120 studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchHH-120HH-120 (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   
0 0.5 1 1.5 2+ Time to viral- 20% Improvement Relative Risk Time to viral-, higher base.. 29% HH-120 for COVID-19  Song et al.  LATE TREATMENT Is late treatment with HH-120 beneficial for COVID-19? PSM retrospective 168 patients in China (August - October 2022) Faster viral clearance with HH-120 (p=0.001) c19early.org Song et al., J. Medical Virology, May 2023 Favors HH-120 Favors control

Nasal spray of an IgM‐like ACE2 fusion protein HH‐120 accelerates SARS‐CoV‐2 clearance: A single‐center propensity score‐matched cohort study

Song et al., Journal of Medical Virology, doi:10.1002/jmv.28805
May 2023  
  Post
  Facebook
Share
  Source   PDF   All   Meta
PSM analysis of 65 HH-120 patients and 103 controls contemporaneously hospitalized in the same hospital, showing faster viral clearance with HH-120 treatment, with improved results for patients with higher baseline viral load.
time to viral-, 20.0% lower, relative time 0.80, p = 0.001, treatment 65, control 103, propensity score matching.
time to viral-, 28.6% lower, relative time 0.71, p = 0.001, higher baseline viral load, propensity score matching.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Song et al., 25 May 2023, retrospective, China, peer-reviewed, 13 authors, study period 3 August, 2022 - 7 October, 2022.
This PaperHH-120All
Late treatment
is less effective
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit